(Q40954231)

25 September 2017

A double-blind trial of transfer factor vs placebo in multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

1 reference

R. C. Collins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

L. R. Espinoza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

C. R. Plank

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

G. C. Ebers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

R. A. Rosenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

J. B. Zabriskie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

7 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=361313

7 April 2023

publication date

1 July 1978

1 reference

full work available at URL

25 September 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/361313/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361313

Clinical and Experimental Immunology

7 April 2023

published in

1 reference

25 September 2017

33

1 reference

25 September 2017

1

1 reference

25 September 2017

1-11

1 reference

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

25 September 2017

1 reference

12 December 2020

Measles antibodies in multiple sclerosis.

1 reference

12 December 2020

On the evaluation of disability in multiple sclerosis

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

B-cell alloantigen Ag 7a in multiple sclerosis

1 reference

12 December 2020

Recovery of Paramyxovirus from the jejunum of patients with multiple sclerosis

1 reference

12 December 2020

Cell mediated immunity to viral antigens in multiple sclerosis

1 reference

12 December 2020

Immunoglobulin abnormalities in spinal fluid in multiple sclerosis

1 reference

12 December 2020

Cell-mediated immunity in multiple sclerosis.

1 reference

12 December 2020

The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States

1 reference

12 December 2020

A suppression of cellular immunity in patients with multiple sclerosis

1 reference

12 December 2020

Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis.

1 reference

12 December 2020

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

1 reference

12 December 2020

Letter: Lack of antigen response to myxoviruses in multiple sclerosis.

1 reference

12 December 2020

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

1 reference

12 December 2020

Immune response of lymphocytes from patients with multiple sclerosis to phytohemagglutinin, basic protein of myelin and measles antigens

1 reference

12 December 2020

Multiple sclerosis and parainfluenza 1 virus. History of the isolation of the virus and expression of phenotypic differences between the isolated virus and Sendai virus

1 reference

12 December 2020

Transfer factor in cellular immunity

1 reference

12 December 2020

Transfer-factor therapy in multiple sclerosis

1 reference

12 December 2020

Identification of Different Measles Virus-Specific Antibodies in the Serum and Cerebrospinal Fluid from Patients with Subacute Sclerosing Panencephalitis and Multiple Sclerosis

1 reference

12 December 2020

HL-A Antigens and Diseases. I. Multiple Sclerosis

1 reference

12 December 2020

Measles antibody titers of multiple sclerosis patients and their siblings.

1 reference

12 December 2020

HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12

1 reference

12 December 2020

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

12 December 2020

A Blood Test for Multiple Sclerosis Based on the Adherence of Lymphocytes to Measles-Infected Cells

1 reference

12 December 2020

In vitro cellular responsiveness in multiple sclerosis patients to a purified measles virus nuclear core and to other viral antigens

1 reference

12 December 2020

Cytotoxic activity of peripheral blood lymphocytes against HeLa cells persistently infected with measles virus: depressed capacity in multiple sclerosis

1 reference

12 December 2020

HLA antigens in multiple sclerosis

1 reference

12 December 2020

Lymphocytic responses to streptococcal antigens in glomerulonephritic patients

1 reference

12 December 2020

Rabbit antibodies to streptococcal carbohydrates. Influence of primary and secondary immunization and of possible genetic factors on the antibody response

1 reference

12 December 2020

Identifiers

PMCID

1537507

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=361313

7 April 2023

1 reference